Volume 53, Issue 4, Pages (April 1998)

Slides:



Advertisements
Similar presentations
Volume 68, Issue 2, Pages (August 2005)
Advertisements

Volume 66, Issue 2, Pages (August 2004)
The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling 
Volume 61, Issue 4, Pages (April 2002)
Volume 61, Issue 5, Pages (May 2002)
Volume 53, Issue 4, Pages (April 1998)
Volume 60, Issue 4, Pages (October 2001)
Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo 
Localization of the prostacyclin receptor in human kidney
Volume 58, Issue 4, Pages (October 2000)
Volume 55, Issue 6, Pages (June 1999)
Volume 56, Pages S202-S205 (July 1999)
Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells  Edward G. Lynn, Yaw L. Siow, Dr Karmin.
Volume 57, Issue 3, Pages (March 2000)
Michael A. Golden, MD, Y. P. Tina Au, PhD, Richard D
Volume 85, Issue 3, Pages (March 2014)
Volume 59, Issue 4, Pages (April 2001)
Volume 56, Issue 3, Pages (September 1999)
Volume 60, Issue 2, Pages (August 2001)
PDGF regulates gap junction communication and connexin43 phosphorylation by PI 3- kinase in mesangial cells  Jian Yao, Tetsuo Morioka, Takashi Oite  Kidney.
Mohammed S. Razzaque, Ph.D., Takashi Taguchi  Kidney International 
Volume 70, Issue 7, Pages (October 2006)
Volume 56, Issue 4, Pages (October 1999)
The Role of Endothelial Cell Injury in Thrombotic Microangiopathy
Tetsuo Morioka, Jian Yao, Yasuhito Suzuki, Takashi Oite 
Volume 53, Issue 5, Pages (May 1998)
Volume 61, Issue 5, Pages (May 2002)
Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44?  Sandrine Florquin,
Volume 53, Issue 6, Pages (June 1998)
Thomas Quaschning, Jan Galle, Christoph Wanner
Volume 62, Issue 1, Pages (July 2002)
Holger Lawall, MD, Peter Bramlage, MD, PhD, Berthold Amann, MD 
Protein kinase C-δ regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2  Bo Liu,
Volume 61, Issue 1, Pages (January 2002)
Jin H. Li, Xiao R. Huang, Hong-Jian Zhu, Richard Johnson, Hui Y. Lan 
Izabella Z.A. Pawluczyk, Kevin P.G. Harris  Kidney International 
Volume 66, Issue 2, Pages (August 2004)
Glucocorticoid regulation of proteoglycan synthesis in mesangial cells
Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis  Richard D. Kenagy, PhD, Nozomi Fukai,
Volume 60, Issue 2, Pages (August 2001)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 69, Issue 10, Pages (May 2006)
Lysophosphatidylcholine induces platelet-derived growth factor gene expression in a human mesangial cell line  Yoshinori Tone, Susumu Yukawa, Zac Varghese,
Hypoxia-induced adrenomedullin production in the kidney
Lipoprotein-stimulated mesangial cell proliferation and gene expression are regulated by lipoprotein lipase1  Frazier T. Stevenson, Gregory C. Shearer,
Volume 60, Issue 3, Pages (September 2001)
Volume 61, Issue 5, Pages (May 2002)
Angiogenesis and arteriogenesis in limb ischemia
Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF- induced mesangial cell migration  Kim Hansen, Christine K. Abrass 
The vascular secret of Klotho
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 59, Issue 3, Pages (March 2001)
Activation of integrin receptors is required for growth factor–induced smooth muscle cell dysfunction  Kyotaro Mawatari, MD, Bo Liu, PhD, K.Craig Kent,
Volume 71, Issue 10, Pages (May 2007)
Volume 62, Issue 4, Pages (October 2002)
Volume 56, Issue 6, Pages (December 1999)
Volume 56, Issue 2, Pages (August 1999)
Volume 56, Pages S171-S173 (July 1999)
Cultured human glomerular mesangial cells express the C5a receptor
Volume 75, Issue 6, Pages (March 2009)
William G. Couser, Jeffrey W. Pippin, Stuart J. Shankland 
Volume 70, Issue 6, Pages (September 2006)
Volume 57, Issue 4, Pages (April 2000)
A. Khwaja, C.C. Sharpe, M. Noor, B.M. Hendry  Kidney International 
Volume 68, Issue 2, Pages (August 2005)
Volume 55, Issue 4, Pages (April 1999)
Development and differentiation of endothelium
Effects of somatostatin, somatostatin analogs, and endothelial cell somatostatin gene transfer on smooth muscle cell proliferation in vitro  Rajabrata.
Presentation transcript:

Volume 53, Issue 4, Pages 979-985 (April 1998) Autocrine/paracrine role of adrenomedullin in cultured endothelial and mesangial cells  Hideo Michibata, Masashi Mukoyama, M.D., Ph.D., Issei Tanaka, Shin-ichi Suga, Masayo Nakagawa, Rieko Ishibashi, Masahisa Goto, Kenichi Akaji, Yoichi Fujiwara, Yoshiaki Kiso, Kazuwa Nakao  Kidney International  Volume 53, Issue 4, Pages 979-985 (April 1998) DOI: 10.1111/j.1523-1755.1998.00855.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 A typical standard curve of adrenomedullin (AM) and cross-reactivity profiles of its related peptides (A) and dilution curves of culture media (B) in the radioimmunoassay (RIA) for AM with a monoclonal antibody KY-AM-I. Abbreviations and symbols in A are: (•) hAM, human AM; (○) rAM, rat AM; (▴) hAM (15-31); (▵) hAM (1-15); (▪) hAM (27-52); (□) hCGRP-I. In B, symbols and abbreviations are: (○) bEC, bovine endothelial cells; (▵) rVSMC, rat vascular smooth muscle cells; (□) rMC, rat mesangial cells. Kidney International 1998 53, 979-985DOI: (10.1111/j.1523-1755.1998.00855.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Typical high performance-gel permeation chromatography (HP-GPC) profiles of adrenomedullin-like immunoreactivity (AM-LI) in the culture supernatant of bovine endothelial cells (EC; A), rat vascular smooth muscle cells (VSMC; B), and rat mesangial cells (MC; C). Arrows denote elution positions of a series of myoglobins of a polypeptide molecular weight calibration kit (Pharmacia), void volume (Vo) and total volume (Vt). The elution position of synthetic AM is also indicated. Kidney International 1998 53, 979-985DOI: (10.1111/j.1523-1755.1998.00855.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Adrenomedullin (AM)-stimulated increase of cAMP production in cultured bovine endothelial cells (EC; A), rat vascular smooth muscle cells (VSMC; B), and rat mesangial cells (MC; C). Values are expressed as the mean ±SEM (N = 4). B is basal. Kidney International 1998 53, 979-985DOI: (10.1111/j.1523-1755.1998.00855.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 Effects of pretreatment with the monoclonal antibody KY-AM-I (▪) or control IgG () on basal and AM-stimulated cAMP production in cultured bovine endothelial cells (EC; □). Values are expressed as the mean ±SEM (N = 6). *P < 0.01, **P < 0.001. Kidney International 1998 53, 979-985DOI: (10.1111/j.1523-1755.1998.00855.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 Inhibitory effects of adrenomedullin (AM) on platelet-derived growth factor (PDGF)-stimulated3H-thymidine incorporation into cultured bovine endothelial cells (EC; A), rat vascular smooth muscle cells (VSMC; B), and rat mesangial cells (MC; C). Values are expressed as the mean ±SEM (N = 6). *P < 0.05, **P < 0.01, as compared to the levels with PDGF alone. Kidney International 1998 53, 979-985DOI: (10.1111/j.1523-1755.1998.00855.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 6 Effects of pretreatment with the monoclonal antibody (MAb) on basal 3H-thymidine incorporation into cultured endothelial cells (EC). Symbols are: (□) basal level (B) with vehicle; () mouse IgG (50 μg/ml); () low dose of MAb KY-AM-I (1 μg/ml); (▪) high dose of KY-AM-I (50 μg/ml). Values are expressed as the mean ±SEM (N = 6). *P < 0.01, **P < 0.001, as compared to basal. Kidney International 1998 53, 979-985DOI: (10.1111/j.1523-1755.1998.00855.x) Copyright © 1998 International Society of Nephrology Terms and Conditions